Post Transplant Study
A Retrospective Evaluation of Sensipar Use in Renal Transplant Recipients
2 other identifiers
observational
50
0 countries
N/A
Brief Summary
Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
November 2, 2006
CompletedFirst Posted
Study publicly available on registry
November 6, 2006
CompletedDecember 28, 2007
December 1, 2007
November 2, 2006
December 20, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Adults \>= 18 years old
- Subjects who have received Sensipar for a duration of at least 3 months, beginning at least 3 months after a kidney transplant. Subjects must have begun Sensipar teatment no later than Februry 28, 2005 at treating physician's discretion.
You may not qualify if:
- Subjects who received Sensipar before undergoing a kidney transplant
- Subjects receiving dialysis post-transplant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Amgenlead
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MD
Amgen
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 2, 2006
First Posted
November 6, 2006
Study Start
August 1, 2005
Last Updated
December 28, 2007
Record last verified: 2007-12